KZR Kezar Life Sciences Inc.

Kezar Life Sciences Inc is a clinical-stage biotechnology company. It is engaged in discovering and developing novel small molecule therapeutics to treat unmet needs in autoimmunity and cancer.

$13.75  -1.05 (-7.10%)
As of 12/03/2021 15:59:57 EST     IEX book   CBOE book


Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Small cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  06/21/2018
Outstanding shares:  49,146,498
Average volume:  3,628,567
Market cap:   $727,368,170
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    49372L100
ISIN:        US49372L1008
Sedol:      BFMLG29
Valuation   (See tab for details)
PE ratio:   0.00
PB ratio:   5.58
PS ratio:   0.00
Return on equity:   -42.99%
Net income %:   0.00%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy